Figure 2.

Tumor markers, hormone levels, and breast cancer subtypes. (A) CA153, (B) CA125, (C) CEA, and (D) combined three markers; (E) prolactin (PRL), (F) testosterone, (G) follicle‐stimulating hormone (FSH), (H) estradiol (E2), (I) progesterone, (J) luteinizing hormone (LH), and (K) combined six hormones